Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
- Conditions
- Soft Tissue Sarcoma
- Registration Number
- NCT03994627
- Lead Sponsor
- Eli Lilly and Company
- Brief Summary
The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of soft tissue sarcoma (STS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- APPROVED_FOR_MARKETING
- Sex
- All
- Target Recruitment
- Not specified
- Are currently receiving olaratumab and who, in consultation with their treating physician, want to continue their course of therapy.
- Have metastatic or locally advanced unresectable soft tissue sarcoma not amenable to curative treatment with surgery or radiotherapy.
- Have given written informed consent.
- Have an absolute neutrophil count (ANC) ≥1,000/microliter.
- Females of childbearing potential and males must agree to use highly effective contraceptive precautions during treatment with olaratumab and up to 3 months following the last dose of olaratumab. A highly effective method of birth control is defined as one that results in a low failure rate (that is, <1% per year) when used consistently and correctly, such as implants, injectables, combined oral contraceptives, some intrauterine contraceptive devices (IUDs), sexual abstinence, or a vasectomized partner.
- Breastfeeding (patients who discontinue breastfeeding would be considered eligible).
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (87)
Ironwood Cancer & Research Centers
🇺🇸Glendale, Arizona, United States
Marin Specialty Care, Inc
🇺🇸Greenbrae, California, United States
The Angeles Clinic & Research Institute
🇺🇸Los Angeles, California, United States
Kaiser Permanente Los Angeles Medical Center
🇺🇸Los Angeles, California, United States
Kaiser Permanente West Los Angeles
🇺🇸Los Angeles, California, United States
Kaiser Permanente Moreno Valley
🇺🇸Moreno Valley, California, United States
University of Colorado Health Hospital
🇺🇸Aurora, Colorado, United States
UCHealth Cancer Center
🇺🇸Fort Collins, Colorado, United States
Baptist MD Anderson Cancer Center
🇺🇸Jacksonville, Florida, United States
Mayo Clinic in Florida
🇺🇸Jacksonville, Florida, United States
Scroll for more (77 remaining)Ironwood Cancer & Research Centers🇺🇸Glendale, Arizona, United States